Monitoring of plasmatic vancomycin level after intraperitoneal administration in dialysis-associated peritonitis

被引：0
|
作者：
Cadenas Mancenido, A. [1 ]
Ordorica Lopez, R. [1 ]
Alvarez Cabrera, R. C. [1 ]
Martinez Belotto, M. [1 ]
Valentin Munoz, M. D. L. O. [1 ]
Sanchez Santiago, M. B. [1 ]
Lavin Alconero, L. [1 ]
Garcia Saiz, M. M. [1 ]
机构：
[1] Hosp Univ Marques Valdecilla, Santander, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2024年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
57
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [21] Peritoneal Dialysis-Associated Peritonitis: Unfinished Business
    Wilkie, Martin
    PERITONEAL DIALYSIS INTERNATIONAL, 2014, 34 (02): : 149 - U1150
  • [22] Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis
    Wong, KM
    Chan, YH
    Cheung, CY
    Chak, WL
    Choi, KS
    Leung, SH
    Leung, J
    Chau, KF
    Tsang, DNC
    Li, CS
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (01) : 127 - 131
  • [23] Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications
    Hartinger, Jan Miroslav
    Michalickova, Danica
    Dvorackova, Eliska
    Hronova, Karolina
    Krekels, Elke H. J.
    Szonowska, Barbora
    Bednarova, Vladimira
    Benakova, Hana
    Kroneislova, Gabriela
    Zavora, Jan
    Tesar, Vladimir
    Slanar, Ondrej
    PHARMACEUTICS, 2023, 15 (05)
  • [24] Pseudomonas pseudoalcaligenes Peritoneal Dialysis-Associated Peritonitis
    Hage, J. E.
    Schoch, P. E.
    Cunha, B. A.
    PERITONEAL DIALYSIS INTERNATIONAL, 2013, 33 (02): : 223 - 224
  • [25] Peritoneal Dialysis-Associated Peritonitis with Kytococcus schroeteri
    Hazari, Akash
    Rosario Aulet, Alexandra
    Shetty, Anupkumar
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [26] Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis
    Schaefer, F
    Klaus, G
    Müller-Wiefel, DE
    Mehls, O
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1999, 10 (01): : 136 - 145
  • [27] Successful treatment of Aeromonas hydrophila peritoneal dialysis-associated peritonitis using intermittent intraperitoneal gentamicin
    Eisele, G
    Bailie, GR
    CLINICAL NEPHROLOGY, 1995, 44 (06) : 402 - 402
  • [28] An investigation into the correlation between intraperitoneal teicoplanin concentrations and treatment outcomes in peritoneal dialysis-associated peritonitis
    Wang, Lulu
    Fan, Jiangqing
    Chen, Xuejie
    Lei, Wenpu
    Jiang, Chunming
    Liu, Hang
    Yang, Yun
    Shen, Jizhong
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [29] Risk factors for peritoneal dialysis-associated peritonitis
    Wang, Hongyue
    Wang, Xiangtuo
    Dou, Haichuan
    Li, Chenhao
    Cui, Mingji
    Gu, Chunmei
    Yang, Liming
    EUROPEAN JOURNAL OF INFLAMMATION, 2018, 16
  • [30] Prediction of outcomes for peritoneal dialysis-associated peritonitis
    Chow, Kai-Ming
    Szeto, Cheuk-Chun
    PERITONEAL DIALYSIS INTERNATIONAL, 2008, 28 (04): : 340 - 342
12345